<<The company has increased estimates for Integrilin sales to $65 - $70 million this year, $175 - $200 million for 2000, and $300 - $350 million for 2001.>
<Total sales of INTEGRILIN, as reported to COR by Schering-Plough, were $11,300,000 for the quarter ended March 31, 1999, as compared to
$8,400,000 for the quarter ended December 31, 1998, a 35% increase. >
<Contract revenues for the quarter ended March 31, 1999 included $5,668,000 of copromotion revenue related to the sales of INTEGRILIN by Schering-Plough>
The actual compared to total year estimates show quite large growth assumptions as you can see... If this really pans out you've got a great little company here.
dAK |
